What’s Benitec Biopharma Limited Ads (NASDAQ:BNTC) Upside After This Short Interest Decrease?

September 17, 2017 - By Marry Poplack

 What's Benitec Biopharma Limited Ads (NASDAQ:BNTC) Upside After This Short Interest Decrease?

The stock of Benitec Biopharma Limited Ads (NASDAQ:BNTC) registered a decrease of 19.38% in short interest. BNTC’s total short interest was 74,900 shares in September as published by FINRA. Its down 19.38% from 92,900 shares, reported previously. With 11,600 shares average volume, it will take short sellers 7 days to cover their BNTC’s short positions. The short interest to Benitec Biopharma Limited Ads’s float is 1.06%.

The stock decreased 0.98% or $0.02 on September 15, reaching $2.03. About 10,286 shares traded. Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) has risen 56.67% since September 17, 2016 and is uptrending. It has outperformed by 39.97% the S&P500.

Benitec Biopharma Limited is a biotechnology company. The company has market cap of $20.92 million. The Firm is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property ; development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. It currently has negative earnings. The Company’s In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic.

More recent Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) news were published by: Marketwatch.com which released: “2.04” on December 30, 2013. Also Benzinga.com published the news titled: “Arbutus Biopharma Taken Off Of Chardan’s Sell List” on June 16, 2016. Quotes.Wsj.com‘s news article titled: “Benitec Biopharma Ltd. ADR” with publication date: July 31, 2015 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.